Although we are currently continuing to evaluate the clinical significance of L858R ctDNA kinetics measured by NOIR-SS during EGFR-TKI treatment, further studies are warranted to establish the usefulness of NOIR-SS for managing patients with cancer. This evidence concerns the gene EGFR and cancer.